Healthcare Industry Financial Valuations - Q3' 2003


Regular Price: USD 1,950.00

Special Price USD 1,365.00

30% OFF

* Required Fields

Regular Price: USD 1,950.00

Special Price USD 1,365.00


Be the first to review this product

The objective of this study is to evaluate the present financial state of the U.S. Healthcare Industry and present financials of top pharmaceutical, biotechnology and medical device companies. The study compares healthcare stocks, investment opportunities, and mergers and acquisitions in different healthcare segments. Movers and Shakers section includes interviews with CEOs of leading healthcare companies and their perspective of healthcare industry.

Table of Contents

Healthcare Industry Financial Valuations - Q3' 2003, Healthcare Industry Financial ValuationsOverviewIntroductionAgendaResearch Scope and MethodologyThe Healthcare IndustryIntroductionHealthcare Industry - SegmentationKey Healthcare Statistics - WorldHealthcare Industry Revenues - WorldThe Pharmaceutical IndustryIntroductionPharmaceutical Industry Revenues by Geographical Regions - WorldPharmaceutical Industry - Patent ExpirationsPharmaceutical Companies - Top 50 (1-16)Pharmaceutical Companies - Top 50 (17-33)Pharmaceutical Companies - Top 50 (34-50)Movers and Shakers - AllerganThe Biotechnology IndustryIntroductionBiotechnology Industry Revenues by Geographical Regions - WorldBiotechnology Companies - Top 50 (1-16)Biotechnology Companies - Top 50 (17-33)Biotechnology Companies - Top 50 (34-50)Movers and Shakers - Gen-ProbeThe Medical Devices IndustryIntroductionMedical Devices Industry RevenuesMedical Devices Industry - ObservationsMedical Devices Industry - The Future Looks BrightMedical Devices Industry - Opportunities and Strategies - IMedical Devices Industry - Opportunities and Strategies - IIMedical Devices Companies - Top 15Movers and Shakers - BiometHealthcare StocksIntroductionPublic Market ValuationsIPO Class of 2000-01Performance Valuations - Healthcare FacilitiesPerformance Valuations - Medical Devices SegmentPerformance Valuations - Scientific & Instruments SegmentMovers and Shakers - QiagenInvestment Opportunity - The Healthcare IndustryIntroductionAreas of OpportunityHealthcare Valuations by SectorVenture Capital - The Healthcare IndustryVenture-backed IPOs by IndustryVenture Capital Healthcare Investment ActivityWhat's Getting Funding?Venture Investments 1999-2001Medical Devices Investments Since 2000IPO Market Window Closed TodayVenture Funding - Deals by Industry/Company/StateVenture Funding - Top 60 DealsVenture Funding - 2002 versus 2003Movers and Shakers - SpacelabsMergers and Acquisitions - The Healthcare Industry Mergers and Acquisitions 2002-03Healthcare M&A 2002M&A Target AdvisorsTop LendersM&A - DevicesMerger-related Charges - Case StudiesPost Deal Stock Returns - Industry Case StudiesM&A Post Deal EarningsSummary and ObservationsHealthcare TrendsSummary and ObservationsFrost & Sullivan AwardsFrost & Sullivan AwardsThe Midas AwardThe Golden Goose AwardThe Fort Knox AwardThe Diviner AwardMovers and Shakers - Smith & NephewDecision Support DatabasesIntroductionHealthcare Expenditure by Geographical RegionsGovernment Healthcare Expenditure by Geographical RegionsPer Capita Healthcare Expenditure by Geographical RegionsNominal Gross Domestic Product by Geographical RegionsHealthcare Expenditure as Percent of GDP by Geographical RegionsHospitals by Geographical RegionsHospital Beds by Geographical RegionsPhysicians by Geographical RegionsNursing Staff by Geographical RegionsMale Population Aged 65 Years and above by Geographical RegionsFemale Population Aged 65 Years and above by Geographical RegionsBiotechnology Companies by Geographical RegionsFrost & SullivanHealthcare TeamFrost & Sullivan CapabilitiesFrost & Sullivan AdvantagesFrost & Sullivan Consulting ClientsFrost & Sullivan Growth ConsultingFrost & Sullivan Growth Partnership

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.